Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2020 / Aug / Reclassifying Ocular Pathology
Histology Histology Oncology Guidelines and Recommendations

Reclassifying Ocular Pathology

What does it take to establish an accurate, understandable classification system for conjunctival epithelial pigmentations?

08/18/2020 1 min read

Share

Eye Pathologists: Ralph C. Eagle Jr., one of the most critically important ocular pathologists in the world, and Tatyana Milman, who joined the Wills Eye Faculty.

The accurate classification and interpretation of pathology has important prognostic implications. Though some pigmented blemishes of the conjunctiva are benign and do not require close follow-up or treatment, others progress to conjunctival melanoma, a malignant tumor with a high potential for recurrence on (up to 50 percent) and a distant metastasis and death (20-30 percent at five years). An ideal classification system needs to be highly accurate, easy for pathologists and ophthalmologists to use, and have excellent inter-observer reproducibility.

Tatyana Milman, Ocular Pathologist at Wills Eye, says, “We are in the midst of re-appraising the two most commonly used classification systems: the primary acquired melanosis (PAM) system, and validating the recently developed WHO 4th edition of Eye Tumours classification system.”

Identifying and designing the ideal classification system is not without its challenges. Milman’s team identified five key barriers: difficulty in finding cases of primary conjunctival epithelial pigmentations that were not previously operated on (as this influences outcome); cases with long-term follow-up (progression to melanoma occurs on average 2.5 years after initial surgery); finding cases that were operated on with the same technique (as this also influences outcome); having identical material reviewed by a large panel of international experts; and, finally, available gold standards in interpretation.

“We selected 83 cases of pigmented conjunctival epithelial lesions that fulfilled our inclusion criteria – primary surgeries, handled uniformly by oncology service, with at least three years of follow-up information from the records of our oncology service,” Milman notes. “We reviewed the histologic slides for adequacy, then scanned the slides with virtual scanning technology to create digital slides, which were then displayed on a shared portal on the internet and scored by 12 international ophthalmic pathology experts." 

"These experts included Robert Folberg, the originator of the PAM classification system, Sarah Coupland, the originator of the C-MIN classification system, and members of the panel that developed the recent WHO classification – Charles Eberhart, Hans Grossniklaus, Steffen Heegaard, Sarah Coupland, Hardeep Mudhar and Ralph Eagle.”

The accuracy of each system for predicting recurrence and progression to melanoma and the agreement between the observers have been analyzed.  The time required for scoring with each classification system also has been assessed. Milman and her team now look forward to the final results.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Your Newest Colleague?
Histology
Your Newest Colleague?

January 6, 2022

1 min read

The need for AI-based end-to-end biomarkers in oncology

Biospecimen Access For Biotechs
Histology
Biospecimen Access For Biotechs

February 14, 2022

1 min read

Quality, provenance, and “taking pot luck”

Case of the Month
Histology
Case of the Month

February 21, 2022

1 min read

The Art of the Laboratory
Histology
The Art of the Laboratory

March 25, 2022

1 min read

For the seventh time, we asked you to share the images you think capture the most beautiful, educational, or amusing aspects of pathology – and you delivered. Welcome to our gallery tour of the most visually striking discipline in medicine!

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.